Cargando…

Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits

Glioblastoma (GBM) is characterized by fast-growing cells, genetic and phenotypic heterogeneity, and radio-chemo-therapy resistance, contributing to its dismal prognosis. Various medical comorbidities are associated with the natural history of GBM. The most disabling and greatly affecting patients’...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stella, Manuela, Baiardi, Giammarco, Pasquariello, Stefano, Sacco, Fabio, Dellacasagrande, Irene, Corsaro, Alessandro, Mattioli, Francesca, Barbieri, Federica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953000/ https://www.ncbi.nlm.nih.gov/pubmed/36831117 http://dx.doi.org/10.3390/biomedicines11020582

Ejemplares similares

Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies
por: Bajetto, Adriana, et al.
Publicado: (2020)

Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets
por: Thellung, Stefano, et al.
Publicado: (2022)

Development and Validation of a Novel LC-MS/MS Method for a TDM-Guided Personalization of HSCT Conditioning with High-Dose Busulfan in Children
por: Cafaro, Alessia, et al.
Publicado: (2023)

Prescriptive Appropriateness: Inhospital Adherence to Proton Pump Inhibitors Deprescription Flow Chart
por: Baiardi, Giammarco, et al.
Publicado: (2023)

The Clinical Efficacy of Multidose Oritavancin: A Systematic Review
por: Baiardi, Giammarco, et al.
Publicado: (2023)

The effects of antiepileptic drugs on the growth of glioblastoma cell lines
por: Lee, Ching-Yi, et al.
Publicado: (2016)

Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method
por: Pigliasco, Federica, et al.
Publicado: (2023)

Antitumoral Activity of Molecular Hydrogen and Proton in the Treatment of Glioblastoma: An Atypical Pharmacology?
por: Rochette, Luc, et al.
Publicado: (2023)

Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity
por: Thellung, Stefano, et al.
Publicado: (2019)

Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells
por: Würth, Roberto, et al.
Publicado: (2020)

Antiepileptic Therapy of Abrus cantoniensis: Evidence from Network Pharmacology
por: Wang, Yue, et al.
Publicado: (2022)

Boron Vehiculating Nanosystems for Neutron Capture Therapy in Cancer Treatment
por: Ailuno, Giorgia, et al.
Publicado: (2022)

Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells
por: Corsaro, Alessandro, et al.
Publicado: (2016)

Deprescribing Strategies: A Prospective Study on Proton Pump Inhibitors
por: Calvini, Giulia, et al.
Publicado: (2023)

Influence of Enzyme-Inducing Antiepileptic Drugs on Trough Level of Imatinib in Glioblastoma Patients
por: Pursche, Stefan, et al.
Publicado: (2008)

Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors
por: Bajetto, Adriana, et al.
Publicado: (2017)

Antiepileptic Drugs
por: Prichard, J. W.
Publicado: (1974)

Antiepileptic Overdose
por: Murty, Shakuntala
Publicado: (2019)

Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System
por: Barbieri, Federica, et al.
Publicado: (2014)

Kaleidoscopic Hues of Antiepileptics in Pediatric Population: Comparison of Prevailing Antiepileptics
por: Rout, Abhisek, et al.
Publicado: (2023)

Antitumor Activity of Curcumin in Glioblastoma
por: Walker, Blake C., et al.
Publicado: (2020)

Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem Cells †
por: Thellung, Stefano, et al.
Publicado: (2019)

Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase
por: Calapai, Fabrizio, et al.
Publicado: (2023)

Antiepileptic drugs and suicidality
por: Britton, Jeffery W, et al.
Publicado: (2010)

Antiepileptic drugs and breastfeeding
por: Davanzo, Riccardo, et al.
Publicado: (2013)

Teratogenicity of Antiepileptic Drugs
por: Güveli, Betül Tekin, et al.
Publicado: (2017)

The perils of antiepileptic toxicity
por: Madan, Arushi, et al.
Publicado: (2020)

Crocetin Extracted from Saffron Shows Antitumor Effects in Models of Human Glioblastoma
por: Colapietro, Alessandro, et al.
Publicado: (2020)

Susceptibility Testing of Colistin for Acinetobacter baumannii: How Far Are We from the Truth?
por: Sacco, Federica, et al.
Publicado: (2021)

Antiepileptic drugs and bone metabolism
por: Valsamis, Helen A, et al.
Publicado: (2006)

Cognitive Effects of Antiepileptic Drugs
por: Park, Sung-Pa, et al.
Publicado: (2008)

Antiepileptic drugs in migraine prophylaxis
por: Mazzotta, Giovanni, et al.
Publicado: (2004)

Rational Polytherapy with Antiepileptic Drugs
por: Lee, Jong Woo, et al.
Publicado: (2010)

Hypersensitivity to antiepileptic drugs in children
por: Atanaskovic-Markovic, Marina, et al.
Publicado: (2014)

Current Research on Antiepileptic Compounds
por: Wei, Cheng-Xi, et al.
Publicado: (2015)

Adherence to Antiepileptic Therapy in Adults
por: Chinnaiyan, Sowmya, et al.
Publicado: (2017)

The Use of New Antiepileptic Drugs
por: Chadwick, David
Publicado: (1999)

Pharmacovigilance on cannabidiol as an antiepileptic agent
por: Ammendolia, Ilaria, et al.
Publicado: (2023)

Levetirazetam: antiepileptic-induced psychosis
por: Vilella Martín, C., et al.
Publicado: (2022)

Antitumor Effects of Ral-GTPases Downregulation in Glioblastoma
por: Cemeli, Tània, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_agftlcan3opevg3443ks9kvbnf